BPTH Stock Price History and Quote Analysis Insights for Investors
Bio-Path Holdings, Inc.
Stock Price Today
Bio-Path Holdings, Inc. (BPTH) stock remained unchanged at $0.64 a share on NASDAQ. The stock opened at $0.64, fluctuating between $0.62 to $0.65 during the session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
Company Information
| Employees | 10 |
| Beta | 0.22 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Bio-Path Holdings, Inc. (NASDAQ: BPTH) stock price is $0.64 in the last trading session. During the trading session, BPTH stock reached the peak price of $0.65 while $0.62 was the lowest point it dropped to. The percentage change in BPTH stock occurred in the recent session was 0% while the dollar amount for the price change in BPTH stock was -.
The NASDAQ listed BPTH is part of Biotechnology industry that operates in the broader Healthcare sector. Bio-Path Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Peter H. Nielsen MBA
Co-Founder, Chairman, Chief Executive Officer, Pres, Chief Financial Officer & Treasurer
Dr. Thomas A. Walker Ph.D.
Consultant
Dr. Alan MacKenzie Ph.D.
Consultant
Mr. Anthony Price
Senior Vice President of Fin., Accounting & Admin.
Dr. Ana Tari Ashizawa Ph.D., MBA
Senior Vice President of Research, Devel. & Clinical Design
Dr. Jeffery Lancet M.D.
Consultant
Ms. Victoria Lake Rac
Regulatory Consultant
BPTH's closing price is 8.47% higher than its 52-week low of $0.59 where as its distance from 52-week high of $12.00 is -94.67%.
Number of BPTH employees currently stands at 10.
Official Website of BPTH is: https://www.biopathholdings.com
BPTH could be contacted at phone 832 742 1357 and can also be accessed through its website. BPTH operates from 4710 Bellaire Boulevard, Bellaire, TX 77401, United States.
BPTH stock volume for the day was 11.82K shares. The average number of BPTH shares traded daily for last 3 months was 1.19M.
The market value of BPTH currently stands at $2.76M with its latest stock price at $0.64 and 4.31M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com